MedTrace Logo

Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens

NCT00495313 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2008-12-16

No results posted yet for this study

Summary

To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%

Conditions

  • Rosacea

Interventions

DRUG

doxycycline

COL-101, QD plus metronidazole

DRUG

doxycycline

40 mg with metronidazole QD

Sponsors & Collaborators

  • CollaGenex Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Christopher V Powala, JD · CollaGenex Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00495313 on ClinicalTrials.gov